Sales & Marketing Just call it ‘good marketing’: Dan Gandor on why omnichannel... A Q&A with EVERSANA's new Head of Omnichannel and Digital Transformation covers omnichannel, AI, pharma marketing headwinds, and more.
News EVERSANA adds AI to medical, legal and regulatory reviews A new AI-powered solution from EVERSANA aims to take the pain out of medical, legal and regulatory (MLR) reviews.
Patients How pharma is tackling new direct-to-patient programmes At Reuters Pharma USA, executives from AstraZeneca, Gilead, Kyowa Kirin, and EVERSANA discussed the what, why, and how of direct-to-patient models.
Patients Direct-to-patient is more than just telehealth – with EVERSA... Hear from EVERSANA's Faruk Abdullah in this video interview as he explains why direct-to-patient strategies go beyond telehealth.
News EVERSANA joins with Veeva in push to 'pharmatise AI' EVERSANA has joined the growing roster of companies partnering with Veeva on the development of GenAI applications for the life sciences industry.
News Lyfegen partners EVERSANA on pricing, access resource Lyfegen and EVERSANA have joined forces to help pharma companies navigate an increasingly complex global drug pricing and access environment.
News US pharma tariffs of up to 100% finalised by Trump Trump signs his pharma tariffs executive order, which won't affect most large pharma groups but could deal a hefty blow to smaller companies.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.